WEED, Inc. (OTCPK: BUDZ)
Health Care · Pharmaceuticals · US
$0.03
-0.16% today · -15.7% 1Y
WEED, Inc. (OTCPK: BUDZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.06M and employs 2 people.
Over the last twelve months the share price has lost 15.7%, trading between 0.02 and 0.08.
Tweenvest scores WEED, Inc. across four factors: quality 7/100. Its strongest factor is quality.
BUDZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.06M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.42
- 52-week high
- $0.08
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 148.31M
- Employees
- 2
- Next earnings
- —
About WEED, Inc.
Operating from its headquarters in Tucson, Arizona, WEED, Inc., along with its associated entities, is dedicated to the research, development, and practical application of cannabis-based compounds for therapeutic use in human diseases. The company, which was founded in 1999, officially adopted the name WEED, Inc. in February 2015, having previously been known as United Mines, Inc.
- ISIN
- US9485081064
- Founded
- 1999
- Listed since
- Apr 5, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,244.96 | -0.83% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.49 | +0.83% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.73 | -1.19% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.